Extended Spectrum Beta-Lactamases: A Global Health Concern
Author Information
Author(s): Rishi H.-P. Dhillon, John Clark
Primary Institution: Imperial College Healthcare NHS Trust
Hypothesis
The rise of extended spectrum beta-lactamases (ESBLs) poses a significant threat to public health due to increased antibiotic resistance.
Conclusion
ESBL-producing bacteria are associated with higher morbidity and mortality rates, and their prevalence is rising globally.
Supporting Evidence
- ESBLs are primarily produced by Enterobacteriaceae, particularly Klebsiella pneumoniae and Escherichia coli.
- Hospital-acquired infections are a major concern due to the prevalence of ESBL-producing bacteria.
- CTX-M enzymes are becoming the predominant type of ESBL in Europe and East Asia.
Takeaway
Some bacteria can resist common antibiotics, making it harder to treat infections, especially in hospitals. This is a big problem for doctors.
Methodology
The article reviews the epidemiology and management of infections caused by ESBL-producing bacteria.
Limitations
The article does not provide specific data on the effectiveness of various treatment options against ESBLs.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website